A Phase I dose escalation trial of HMPL-689 in patients with hematologic malignancies.
Phase of Trial: Phase I
Latest Information Update: 29 Aug 2016
At a glance
- Drugs HMPL 689 (Primary)
- Indications Haematological malignancies
- Focus Adverse reactions; Therapeutic Use
- 29 Aug 2016 New trial record
- 02 Aug 2016 According to Chi-Med media release, company is planning to start this trial H1 2017.